Non-fibrillar oligomeric species of the amyloid ABri peptide, implicated in familial British dementia, are more potent at inducing apoptotic cell death than protofibrils or mature fibrils11Edited by J. Karn
The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“synthetic ABri peptide, especially the oligomeric form, induces apoptotic cell death in vitro while the wild type peptide is not toxic to cells (30,31).”
From Proteolytic Processing of Familial British Dementia-associated BRI Variants (2002) · cites this paper as [31]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse
Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160
Bard, F., Cannon, C., Barbour, R., Burke, R.-L., Games, D., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., et al. (2000) · Nature Medicine · doi:10.1038/78682 · Cited by 2,012
Mucke, L., Masliah, E., Yu, G.-Q., Mallory, M., Rockenstein, E. M., Tatsuno, G., Hu, K., Kholodenko, D., Johnson-Wood, K., & McConlogue, L. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-11-04050.2000 · Cited by 1,856
Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.
Lorenzo, A., & Yankner, B. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12243 · Cited by 1,324
Plaque-independent disruption of neural circuits in Alzheimer’s disease mouse models
Hsia, A. Y., Masliah, E., McConlogue, L., Yu, G.-Q., Tatsuno, G., Hu, K., Kholodenko, D., Malenka, R. C., Nicoll, R. A., & Mucke, L. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.6.3228 · Cited by 1,123
Amyloid β-Protein Fibrillogenesis
Walsh, D. M., Hartley, D. M., Kusumoto, Y., Fezoui, Y., Condron, M. M., Lomakin, A., Benedek, G. B., Selkoe, D. J., & Teplow, D. B. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.36.25945 · Cited by 1,046
Moechars, D., Dewachter, I., Lorent, K., Reversé, D., Baekelandt, V., Naidu, A., Tesseur, I., Spittaels, K., Haute, C. V. D., Checler, F., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.10.6483 · Cited by 668
A stop-codon mutation in the BRI gene associated with familial British dementia
Vidal, R., Frangione, B., Rostagno, A., Mead, S., Révész, T., Plant, G., & Ghiso, J. (1999) · Nature · doi:10.1038/21637 · Cited by 466
Vidal, R., Révész, T., Rostagno, A., Kim, E., Holton, J. L., Bek, T., Bojsen-Møller, M., Braendgaard, H., Plant, G., Ghiso, J., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.080076097 · Cited by 300
Furin mediates enhanced production of fibrillogenic ABri peptides in familial British dementia
Kim, S.-H., Wang, R., Gordon, D. J., Bass, J., Steiner, D. F., Lynn, D. G., Thinakaran, G., Meredith, S. C., & Sisodia, S. S. (1999) · Nature Neuroscience · doi:10.1038/14783 · Cited by 154
Research works printed but not linked: 34
- Worster-Drought, 1933, Familial cerebral amyloid angiopathy with nonneuritic plaque formation, J. Neurol. Psychopathol., 14, 27, 10.1136/jnnp.s1-14.53.27 · DOI
- Aikawa, 1985, Atypical Alzheimer’s disease with spastic paresis and ataxia, Ann. Neurol., 17, 297, 10.1002/ana.410170313 · DOI · Paper page
- Plant, 1990, Familial cerebral amyloid angiopathy with nonneuritic amyloid plaque formation, Brain, 113, 721, 10.1093/brain/113.3.721 · DOI · Paper page
- Lansbury, 1999, Evolution of amyloid, Proc. Natl Acad. Sci. USA, 96, 3342, 10.1073/pnas.96.7.3342 · DOI · Paper page
- Perutz, 1999, Glutamine repeats and neurodegenerative diseases, Trends Biochem. Sci., 24, 58, 10.1016/S0968-0004(98)01350-4 · DOI · Paper page
- El-Agnaf, 2000, Review, J. Struct. Biol., 130, 300, 10.1006/jsbi.2000.4262 · DOI
- Forloni, 1993, Neurotoxicity of a prion protein fragment, Nature, 362, 543, 10.1038/362543a0 · DOI · Paper page
- El-Agnaf, 1998, Aggregates from mutant and wild-type alpha-synuclein proteins and NAC peptide induce apoptotic cell death in human neuroblastoma cells by formation of beta-sheet and amyloid-like filaments, FEBS Letters, 440, 71, 10.1016/S0014-5793(98)01418-5 · DOI · Paper page
- Roher, 1996, Morphology and toxicity of Abeta-(1–42) dimer derived from neuritic and vascular amyloid deposits of Alzheimer’s disease, J. Biol. Chem., 271, 20631, 10.1074/jbc.271.34.20631 · DOI · Paper page
- Seilheimer, 1997, The toxicity of the Alzheimer’s beta-amyloid peptide correlates with a distinct fiber morphology, J. Struct. Biol., 119, 59, 10.1006/jsbi.1997.3859 · DOI · Paper page
- Walsh, 1997, Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate, J. Biol. Chem., 272, 22364, 10.1074/jbc.272.35.22364 · DOI · Paper page
- El-Agnaf, 2000, Oligomerization and toxicity of beta-amyloid-42 implicated in Alzheimer’s disease, Biochem. Biophys. Res. Commun., 273, 1003, 10.1006/bbrc.2000.3051 · DOI · Paper page
- Lambert, 1998, Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins, Proc. Natl Acad. Sci. USA, 95, 6448, 10.1073/pnas.95.11.6448 · DOI · Paper page
- Hartley, 1999, Protofibrillar intermediates of amyloid beta-protein induce acute electrophysiological changes and progressive neurotoxicity in cortical neurons, J. Neurosci., 19, 8876, 10.1523/JNEUROSCI.19-20-08876.1999 · DOI · Paper page
- Howlett, 1999, Biological activity associated with a high molecular weight form of β-amyloid, Alzheimer’s Rep., 2, 71
- Bhatia, 2000, Fresh and globular amyloid beta protein (1–42) induces rapid cellular degeneration, FASEB J., 14, 1233, 10.1096/fasebj.14.9.1233 · DOI · Paper page
- Ward, 2000, Fractionation and characterization of oligomeric, protofibrillar and fibrillar forms of beta-amyloid peptide, Biochem. J., 15, 137, 10.1042/bj3480137 · doi:10.1042/bj3480137 · Paper page
- Zhu, 2000, Fresh and nonfibrillar amyloid beta protein(1–40) induces rapid cellular degeneration in aged human fibroblasts, FASEB J., 14, 1244, 10.1096/fasebj.14.9.1244 · DOI · Paper page
- Sian, 2000, Oligomerization of beta-amyloid of the Alzheimer’s and the Dutch-cerebral-haemorrhage types, Biochem. J., 349, 299, 10.1042/bj3490299 · doi:10.1042/bj3490299
- Conway, 2000, Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson’s disease, Proc. Natl Acad. Sci. USA, 97, 571, 10.1073/pnas.97.2.571 · DOI · Paper page
- Chiesa, 1998, Neurological illness in transgenic mice expressing a prion protein with an insertional mutation, Neuron, 21, 1339, 10.1016/S0896-6273(00)80653-4 · DOI · Paper page
- Saudou, 1998, Huntingtin acts in the nucleus to induce apoptosis but death does not correlate with the formation of intranuclear inclusions, Cell, 95, 55, 10.1016/S0092-8674(00)81782-1 · DOI · Paper page
- Masliah, 2000, Dopaminergic loss and inclusion body formation in alpha-synuclein mice, Science, 287, 1265, 10.1126/science.287.5456.1265 · DOI · Paper page
- El-Agnaf, 2001, Effect of the disulophide bridge and the C-terminal extension on the oligomerisation of the amyloid peptide ABri implicated in familial British dementia, Biochemistry, 40, 3449, 10.1021/bi002287i · DOI · Paper page
- Cooper, 1974, Selective amyloid staining as a function of amyloid composition and structure. Histochemical analysis of the alkaline Congo red, standardized toluidine blue, and iodine methods, Lab. Invest., 31, 232
- Elghetany, 1988, Methods for staining amyloid in tissues, Stain. Technol., 63, 201, 10.3109/10520298809107185 · DOI · Paper page
- Elghetany, 1989, The congo red stain revisited, Ann. Clin. Lab. Sci., 19, 190
- Shearman, 1995, The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides, J. Neurochem., 65, 218, 10.1046/j.1471-4159.1995.65010218.x · DOI · Paper page
- Liu, 1997, Cytotoxic amyloid peptides inhibit cellular 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction by enhancing MTT formazan exocytosis, J. Neurochem., 69, 2285, 10.1046/j.1471-4159.1997.69062285.x · DOI · Paper page
- Shearman, 1994, Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death, Proc. Natl Acad. Sci. USA, 91, 1470, 10.1073/pnas.91.4.1470 · DOI · Paper page
- Huang, 2000, Alternate aggregation pathways of the Alzheimer beta-amyloid peptide, J. Biol. Chem., 275, 36436, 10.1074/jbc.M005698200 · DOI
- Mead, 2000, Familial British dementia with amyloid angiopathy, Brain, 123, 975, 10.1093/brain/123.5.975 · DOI · Paper page
- Goldberg, 2000, Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson’s disease?, Nature Cell Biol., 2, E115, 10.1038/35041081 · DOI · Paper page
- El-Agnaf, 1998, The N-terminal region of non-A beta component of Alzheimer’s disease amyloid is responsible for its tendency to assume beta-sheet and aggregate to form fibrils, Eur. J. Biochem., 258, 157, 10.1046/j.1432-1327.1998.2580157.x · DOI
Cited by
Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis
Kayed, R., Head, E., Thompson, J. L., McIntire, T. M., Milton, S. C., Cotman, C. W., & Glabe, C. G. (2003) · Science · doi:10.1126/science.1079469 · Cited by 4,064
Caughey, B., & Lansbury, P. T. (2003) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.26.010302.081142 · Cited by 1,650
AGGRESCAN: a server for the prediction and evaluation of "hot spots" of aggregation in polypeptides
Conchillo-Solé, O., de Groot, N. S., Avilés, F. X., Vendrell, J., Daura, X., & Ventura, S. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-65 · Cited by 1,068
Lashuel, H. A., Petre, B. M., Wall, J., Simon, M., Nowak, R. J., Walz, T., & Lansbury, P. T. (2002) · Journal of Molecular Biology · doi:10.1016/s0022-2836(02)00735-0 · Cited by 805
El‐Agnaf, O. M. A., Salem, S. A., Paleologou, K. E., Curran, M. D., Gibson, M. J., Court, J. A., Schlossmacher, M. G., & Allsop, D. (2006) · The FASEB Journal · doi:10.1096/fj.03-1449com · Cited by 715
Self-citation
Metadata
- Authors
- El-Agnaf, O. M. A., Nagala, S., Patel, B. P., & Austen, B. M.
- Venue
- Journal of Molecular Biology
- Publisher
- Elsevier BV
- Published
- 2001-06
- Volume
- 310
- Issue
- 1
- Pages
- 157-168
- ISSN
- 0022-2836
- Cited by
- 59
- References
- 11
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.